Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN42195152
ISRCTN42195152
Completed
未知

Defibrillator After Primary Angioplasty randomised trial

Individual Sponsor (Netherlands)0 sites266 target enrollmentSeptember 12, 2005
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Individual Sponsor (Netherlands)
Enrollment
266
Status
Completed
Last Updated
5 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 12, 2005
End Date
March 31, 2008
Last Updated
5 years ago
Study Type
Interventional

Investigators

Sponsor
Individual Sponsor (Netherlands)

Eligibility Criteria

Inclusion Criteria

  • •1\. ST\-elevation myocardial infarction treated with primary PCI within 30 days and 60 days before randomisation
  • •2\. At least one of the following criteria:
  • •a. Thrombolysis In Myocardial Infarction (TIMI) flow after primary PCI less than three in the infarct related vessel
  • •b. Left ventricular ejection lower than 30% as measured within four days after admission

Exclusion Criteria

  • •1\. Class I indication for ICD implantation
  • •2\. Documented previous myocardial infarction with Left Ventricular Ejection Fraction (LVEF) less than 30%
  • •3\. Age less than 18 years
  • •4\. Heart failure with New York Heart Association functional class IV
  • •5\. Inotropic medication within two weeks before randomisation
  • •6\. Mechanical tricuspid valve
  • •7\. Serious comorbidity such as cancer, with a high likelihood of death during the trial
  • •8\. Advanced cerebrovascular disease
  • •9\. Unwilling or unable to sign the consent form for participation
  • •10\. Females of childbearing age not using medically prescribed contraceptives

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
ExtraVascular Implantable Cardioverter Defibrillator (EV ICD) Pivotal Studyheart rhythm disturbancesventricular fibrillation10007521
NL-OMON54505Medtronic BV30
Active, not recruiting
Phase 3
EV ICD Japan StudyDeveloping, life-threatening ventricular tachyarrhythmias
JPRN-jRCT2032220135Yamamoto Takuto15
Recruiting
Phase 3
ExtraVascular Implantable Cardioverter Defibrillator (EV ICD) Japan Study
JPRN-UMIN000039469Medtronic Japan Co., Ltd.15
Completed
Not Applicable
Inappropriate implantable cardioverter-defibrillator therapy: Frequency, syncope and prognostic factorsife-threatening arrhythmia
JPRN-UMIN000025995Fujita Health University School of Medicine200
Recruiting
Not Applicable
DAPA (Defibrillator After Primary Angioplasty) ¡V Randomized Trial.primary angioplasty for acute MI within 30-60 days with at least one of the following criteria:<br /> 1) TIMI flow after PCI less than 3<br /> 2) left ventricular ejection (LVEF) lower than 30% as measured within 4 days after hospital admission.
NL-OMON28488A.R. Ramdat Misier, MD, PhD, Zwolle, The NetherlandsJ.P. Ottervanger MD, PhD, Zwolle, The NetherlandsProf. M.J. Schalij MD, PhD, Leiden, The NetherlandsProf. F. Zijlstra MD, PhD, Groningen, The NetherlandsE.F.D. Wever MD, PhD, Nieuwegein, The NetherlandsM.J. de Boer, MD, PhD (Zwolle, The Netherlands)W. Beukema, MD (Zwolle, The Netherlands)L. van Erven, MD, PhD (Leiden, The Netherlands)I.C. van Gelder, MD, PhD (Groningen, The Netherlands)700